Adherence to HIV treatment: results from a 1-year follow-up study.
We evaluated adherence to HIV treatments every 4 months during one year in 63 HIV-infected subjects using combination therapies including a protease inhibitor. A total of 18 subjects reported a high level of adherence, 14 in two evaluations, and eight a low level of adherence in all the three evaluations. The remaining 23 subjects (36.5%) reported different levels of adherence to treatment in the three evaluations. These findings suggest that the level of adherence to treatment changes markedly for each patient over time.
Martini
M
M
Italian League for the Fight Against AIDS (LILA), National Research Center, Milan, Italy.
D'Elia
S
S
Paoletti
F
F
Cargnel
A
A
Adriani
B
B
Carosi
G
G
Mazzotta
F
F
Di Pietro
M
M
Filippini
P
P
Nasta
P
P
Cipriani
S
S
Parazzini
F
F
Agnoletto
V
V
D000293:Adolescent; D000328:Adult; D015496:CD4-Positive T-Lymphocytes; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000523:psychology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D010349:Patient Compliance; D011795:Surveys and Questionnaires; D019562:Viral Load
D017320:HIV Protease Inhibitors